LONG BEACH, CA - March 11, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource detailing ...

TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...

LONG BEACH, CA - March 06, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new resource on its ...

Radial today announced publication of a landmark study showing accelerated Deep TMS can treat depression in six days instead of months. The research evaluated BrainsWay's SWIFT™ accelerated Deep ...

DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Restore Brain, a multi-state interventional behavioral health practice specializing in neuromodulation, today shared new clinical insights into how ...

Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...

Moment of Clarity has released a new educational publication titled Transcranial Magnetic Stimulation in California, providing evidence-based insight into how transcranial magnetic stimulation (TMS) ...

CHEYENNE – Cheyenne Regional Medical Center is expanding access to behavioral health care with the addition of NeuroStar Transcranial Magnetic Stimulation therapy, recently cleared by the U.S. Food an ...

Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced today clearance from the U.S. Food & Drug Administration (FDA) for the SPRY ...

As science advances, we have a better understanding how how neuroscience can inform the work of psychotherapy.